Ciprofloxacin Navamedic 2 mg/ ml נורווגיה - נורבגית - Statens legemiddelverk

ciprofloxacin navamedic 2 mg/ ml

navamedic asa - ciprofloksacinlaktat - infusjonsvæske, oppløsning - 2 mg/ ml

Lariam 250 mg נורווגיה - נורבגית - Statens legemiddelverk

lariam 250 mg

cheplapharm arzneimittel gmbh - meflokinhydroklorid - tablett - 250 mg

Rapiscan האיחוד האירופי - נורבגית - EMA (European Medicines Agency)

rapiscan

ge healthcare as  - regadenoson - myokardial perfusjon imaging - hjertetapi - dette legemidlet er kun til diagnostisk bruk. rapiscan er en selektiv coronary vasodilator for bruk som en farmakologisk stress agent for radionuklide myocardial perfusjon imaging (mpi) hos voksne pasienter i stand til å gjennomgå adekvat trening stress.

Meloxicam Bluefish 7.5 mg נורווגיה - נורבגית - Statens legemiddelverk

meloxicam bluefish 7.5 mg

bluefish pharmaceuticals ab - meloksikam - tablett - 7.5 mg

Meloxicam Bluefish 15 mg נורווגיה - נורבגית - Statens legemiddelverk

meloxicam bluefish 15 mg

bluefish pharmaceuticals ab - meloksikam - tablett - 15 mg

Crysvita האיחוד האירופי - נורבגית - EMA (European Medicines Agency)

crysvita

kyowa kirin holdings b.v. - burosumab - hypophosphatemia, familial; hypophosphatemic rickets, x-linked dominant; osteomalacia - legemidler til behandling av bein sykdommer - crysvita is indicated for the treatment of x-linked hypophosphataemia, in children and adolescents aged 1 to 17 years with radiographic evidence of bone disease, and in adults. crysvita is indicated for the treatment of fgf23-related hypophosphataemia in tumour-induced osteomalacia associated with phosphaturic mesenchymal tumours that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.

Lartruvo האיחוד האירופי - נורבגית - EMA (European Medicines Agency)

lartruvo

eli lilly nederland b.v. - olaratumab - sarkom - antineoplastiske midler - lartruvo angis i kombinasjon med doksorubicin for behandling av voksne pasienter med avansert bløtvev sarkomspesialitet som ikke er mottakelig for helbredende behandling med kirurgi eller strålebehandling, og som har ikke blitt behandlet med doksorubicin (se del 5.

Nevanac האיחוד האירופי - נורבגית - EMA (European Medicines Agency)

nevanac

novartis europharm limited - nepafenak - pain, postoperative; ophthalmologic surgical procedures - Øyemidler - nevanac is indicated for: , prevention and treatment of postoperative pain and inflammation associated with cataract surgery;, reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.

Pedea האיחוד האירופי - נורבגית - EMA (European Medicines Agency)

pedea

recordati rare diseases - ibuprofen - ductus arteriosus, patent - hjertetapi - behandling av en hemodynamisk signifikant patentsduktus arteriosus hos premature nyfødte spedbarn mindre enn 34 uker med graviditetsalder.

Azyter 15 mg/ g נורווגיה - נורבגית - Statens legemiddelverk

azyter 15 mg/ g

laboratoires théa s.a.s - azitromycindihydrat - Øyedråper, oppløsning - 15 mg/ g